Sunday, July 5, 2009 Last update: 6:30 PM
Promoting Technology Companies Today for Tomorrow's Future
Optimer Pharmaceuticals to Present at BioCentury NewsMakers Conference
Submitted by admin on 8/28/2008 @ 7:42 AM
Companies mentioned in this article:
Optimer Pharmaceuticals - Biotech
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced today that the Company is scheduled to present on Thursday, September 4, 2008, at 1:30 p.m. ET at the NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel in New York, NY.
A live audio webcast of this presentation will be available on the Company’s website at www.optimerpharma.com, on the investors page. Replays of this presentation will be available for thirty days after the meeting.
About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products for the treatment of serious infections. Optimer has two late-stage anti-infective product candidates. OPT-80 is being developed for the treatment of Clostridium difficile infection, the most common hospital-acquired diarrhea. Prulifloxacin is an antibiotic being developed for the treatment of travelers’ diarrhea, a form of infectious diarrhea. Additional information can be found at http://www.optimerpharma.com.